Characterization of Glycoprotein Complexes Present in Human Cytomegalovirus Envelopes

References

1. Britt W. J. 1984; Neutralizing antibodies detect a disulphide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
   [Google Scholar]
2. Eisenberg R. J., Cerini C. P., Heilman C. J., Joseph A. D., Dietzschold B., Golub E., Long D., Ponce De Leon M., Cohen G. H. 1985; Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. Journal of Virology 56:1014–1017
   [Google Scholar]
3. Farrar G. H., Oram J. D. 1984; Characterization of the human cytomegalovirus envelope glycoproteins. Journal of General Virology 65:1991–2001
   [Google Scholar]
4. Furukawa T., Gonczol E., Starr S., Tolpin M. D., Arbeter A., Plotkin S. A. 1984; HCMV envelope antigens induce both humoral and cellular immunity in guinea pigs. Proceedings of the Society for Experimental Biology and Medicine 175:243–250
   [Google Scholar]
5. Greenaway P. J., Levine D. 1973; Amino acid compositions of simian virus 40 structural proteins. Biochemical and Biophysical Research Communications 52:1221–1227
   [Google Scholar]
6. Hunter W. M., Greenwood F. C. 1962; Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature, London 194:495–496
   [Google Scholar]
7. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
   [Google Scholar]
8. Law K. M., Wilton-Smith P., Farrar G. H. 1985; A murine monoclonal antibody recognising a single glycoprotein within a human cytomegalovirus virion envelope glycoprotein complex. Journal of Medical Virology 17:255–266
   [Google Scholar]
9. Middledorp J. M., Jongsma J., The T. J. 1985; Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera. Journal of Virology 54:240–244
   [Google Scholar]
10. North J. R., Morgan A. J., Thompson L., Epstein M. A. 1982; Purified Epstein-Barr virus M 340, 000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes. Proceedings of the National Academy of Sciences, U.S.A. 79:7504–7508
    [Google Scholar]
11. Nowak B., Sullivan C., Sarnow P., Thomas R., Bricout F., Nicolas J. C., Fleckenstein B., Levine A. J. 1984; Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325–338
    [Google Scholar]
12. Pereira L., Hoffman M., Cremer N. 1982a; Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus infected cell extracts by human sera. Infection and Immunity 36:933–942
    [Google Scholar]
13. Pereira L., Hoffman M., Gallo D., Cremer N. 1982b; Monoclonal antibodies to human cytomegalovirus. Three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infection and Immunity 36:924–932
    [Google Scholar]
14. Pereira L., Hoffman M., Tatsuno M., Dondero D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139:73–86
    [Google Scholar]
15. Rasmussen L., Mullenax J., Nelson R., Merigan T. C. 1985; Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. Journal of Virology 55:274–280
    [Google Scholar]
16. Stinski M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
    [Google Scholar]
17. Talbot P., Almeida J. D. 1977; Human cytomegalovirus: purification of enveloped virions and dense bodies. Journal of General Virology 36345–349
    [Google Scholar]